论文部分内容阅读
目的评价~(99m)Tc－MIBI心／肝比值（H／L）对肝硬化患者预后判断。方法用回顾性队列研究方法，对所有进行H／L测定的肝硬化患者对其不同的Child－Pugh分级的H／L进行生存率分析。结果所有患者随访0.1～63个月，Child-PughA、B、C组的H／L值分别为0.85±0.15,0.99±0.19，1.15±0.27（F＝5.09P＜0.01），H／L≤1.0组的6个月、1年、2年的生存率明显较H／L儿＞1.0组高（分别为：85.9％，57．4％，57.4％和50.0％，39．4％，19．7％，P＜0．01），在Child－PughC级的患者中H／L≤1．0组的6个月、1年、2年的生存率明显较H／L＞1．0对组高（分别为71．4％，42．9％，42．9％和27．3％，18．2％，0）。结论H／L是评价肝硬化患者预后的较为有效的指标，可以和Child－Pugh分级相互补充。
Objective To evaluate the prognostic value of ~ (99m) Tc-MIBI cardiac / hepatic ratio (H / L) in patients with liver cirrhosis. Methods A retrospective cohort study was performed to evaluate the survival of all H-L-treated patients with cirrhosis who had different Child-Pugh grades of H / L. Results All patients were followed up for 0.1 to 63 months. The values of H / L in Child-PughA, B and C groups were 0.85 ± 0.15, 0.99 ± 0.19 and 1.15 ± 0.27, respectively (F = 5.09P <0.01) The 6-month, 1-year and 2-year survival rates in the group were significantly higher than those in the H / L group> 1.0 (85.9%, 57.4%, 57.4% and 50.0%, 39.4% and 19.7, respectively %, P <0.01). The 6-month, 1-year and 2-year survival rates in H / L≤1.0 group were significantly higher than those in H / L> 1.0 group in Child-PughC class (71.4%, 42.9%, 42.9% and 27.3%, 18.2%, 0 respectively). Conclusion H / L is a more effective indicator to evaluate the prognosis of patients with liver cirrhosis, which can be complemented with Child-Pugh classification.